ICRP Publication 87: Managing Patient Dose in Computed Tomography,Used

ICRP Publication 87: Managing Patient Dose in Computed Tomography,Used

Out of Stock
SKU: DADAX0080440835
Brand: Sage Publications
Condition: New
$241.89 $345.56
Sold out Save $103.67
Quantity
Add to wishlist
Add to compare
Sold by Ergodebooks, an authorized reseller.

Processing time: 1-3 days

US Orders Ships in: 3-5 days

International Orders Ships in: 8-12 days

Return Policy: 15-days return on defective items

Payment Option
Payment Methods

Help

If you have any questions, you are always welcome to contact us. We'll get back to you as soon as possible, withing 24 hours on weekdays.

Customer service

All questions about your order, return and delivery must be sent to our customer service team by e-mail at yourstore@yourdomain.com

Sale & Press

If you are interested in selling our products, need more information about our brand or wish to make a collaboration, please contact us at press@yourdomain.com

Computed tomography (CT) examinations can involve relatively high doses to patients. The doses can often approach or exceed levels known with certainty to increase the probability of cancer. The frequency of CT examinations is increasing worldwide and the variety of examinations is also increasing. However, in contrast to the common trend in diagnostic radiology, the rapid developments in CT have not led in general to a reduction of patient doses per examination. Therefore, management of patient dose is crucial. Proper justification of examinations, use of the appropriate technical parameters during examinations, proper quality control, and application of diagnostic reference levels of dose as appropriate would all contribute to this end. There is also scope for further technical development of the equipment used. The present publication aims to provide information in all these respects in order to provide assistance in the successful management of patient dose.

⚠️ WARNING (California Proposition 65):

This product may contain chemicals known to the State of California to cause cancer, birth defects, or other reproductive harm.

For more information, please visit www.P65Warnings.ca.gov.

Recently Viewed